Anatomic Pathology Equipment and Consumables Global Market Report 2024

The anatomic pathology equipment & consumables market size has grown rapidly in recent years. It will grow from $19.77 billion in 2023 to $22.1 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The growth observed in the historical period in the anatomical pathology equipment and consumables market can be attributed to several key factors. These include the increasing prevalence of infectious diseases, strong economic growth in emerging markets, technological advances in the field of pathology, and an increase in the demand for personalized medicines.

The anatomic pathology equipment & consumables market size is expected to see rapid growth in the next few years. It will grow to $32.44 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. Anticipated growth in anatomical pathology equipment and consumables market is driven by factors such as increased reliance on biomarker-based tests, rising pathology training programs, COVID-19 impact, and growing chronic diseases. Key trends include launching new diagnostic products, increased collaboration investments for innovation, integration of AI in pathology equipment, and manufacturing 3D printing equipment for anatomical pathology.


The increasing prevalence of chronic illnesses such as cancer is expected to fuel the demand for anatomic pathology equipment and consumables. According to the American Cancer Society, the USA recorded 1.89 million new cases and 0.6 million deaths due to cancer in 2021. Globally, the four most common cancers - lung, prostate, bowel, and female breast cancers - comprise 43% of all new cancer diagnoses. This rise in cancer incidence rates worldwide is anticipated to drive the need for anatomic pathology equipment and consumables in the market.

The escalating approvals for personalized medicines are set to propel the anatomical pathology equipment and consumables market. Personalized medicines are tailored treatments designed based on individual patient characteristics, including genetics, biomarkers, and other predictive factors determining a patient's response to treatment. Anatomical pathology equipment and consumables play a critical role in personalized medicine, enabling detailed molecular and genetic profiling of patient samples. This profiling assists in customizing treatment strategies based on the unique characteristics of the disease. In 2021, The Personalized Medicine Coalition reported that the FDA's CDER approved 50 new molecular entities (NMEs), with 17 (35%) classified as personalized medicines. Hence, the increasing authorizations for personalized medicines are driving the market for anatomical pathology equipment and consumables.

Companies within the anatomical pathology equipment and consumables market are increasingly investing in innovative technologies to enhance efficiency and reduce test durations. Entities such as Biogenex have introduced automated staining technologies such as Xmatrx and i6000 diagnostics, catering to diverse laboratory requirements. The Matrix systems provide standardized procedures from baking to the final glass coverslip for staining, aiming to prevent cross-contamination. On the other hand, the i6000 diagnostics system, geared for molecular pathology labs, is a high-throughput system specialized for the special staining of clinical samples. It boasts a staining capacity of 200 slides within an 8-hour timeframe, processing 60 slides in just 3 hours.

Major players in the anatomical pathology equipment and consumables market are rolling out advanced systems such as the BenchMark ULTRA PLUS system, designed to streamline lab operations for personnel. This system represents an evolution of the established BenchMark ULTRA, focusing on improving the laboratory experience through integrated hardware, software, and assay functionalities. For instance, in June 2022, Roche, a Swiss-based pharmaceutical company, launched the BenchMark ULTRA PLUS system, a novel slide tissue staining system. This technology modernizes cancer diagnostics by automating previously manual processes, applying chemical solutions to tissue samples. It assists healthcare professionals in identifying crucial cell markers essential for making therapeutic decisions. The system includes features such as user-friendly software, remote monitoring capabilities, an integrated touchscreen interface, and environmentally conscious waste management and packaging.

In September 2022, Epredia, a US-based cancer diagnostics company, successfully acquired MMFrance and Laurypath for an undisclosed amount. This strategic acquisition aligns with Epredia's strategy to expand its cancer diagnostics business. MMFrance and Laurypath, both established in 1987 and based in France, are manufacturers of anatomical pathology products. The integration of MMFrance and Laurypath into Epredia is expected to contribute to the company's growth and capabilities in the field of cancer diagnostics and anatomical pathology.

Major companies operating in the anatomic pathology equipment and consumables market report are Danaher Corporation, F. Hoffmann-La Roche Ltd., Cardinal Health Inc., PHC Group, Agilent Technologies, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, NeoGenomics Laboratories Inc., BioGenex Laboratories, Sakura Finetek USA Inc., Shimadzu Corporation, Bionics Scientific Technologies (P) Ltd., ACMAS Technologies Pvt. Ltd., Labindia Instruments Pvt. Ltd., Hospital Supply Company Pvt. Ltd., Ratek, Leica Biosystem, SORAN, PHC Holdings Corporation, Thermo Fisher Scientific, Becton Dickinson and Company, Epridia, TPL Pathology Labs, ARUP Pathology, Maxdata, Medesa, BMT Medical Technology, Dynex, Medicarom, Hologic Inc., Merck KGaA, Bio SB, Diapath S.p.A., DASA, UW Medicine Pathology, Sunquest, Somatco, ANDAAF Scientific Ltd., Katchey Company Limited.

North America was the largest region in the anatomical pathology equipment and consumables market in 2023. Western Europe was the second largest region in the global anatomical pathology equipment and consumables market report share. The regions covered in the anatomic pathology equipment and consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the anatomic pathology equipment and consumables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The primary products and services in anatomical pathology include instruments, consumables, and services. Instruments utilized in anatomical pathology, such as Wintrobe's tube and Westergren's tube, are employed for various processes in pathology. The applications of anatomical pathology span disease diagnosis, cancer detection, analysis of other diseases, and medical research. These products and services are utilized by diverse end-users, including hospital laboratories, clinical laboratories, and other relevant entities involved in pathology and diagnostics.

The anatomical pathology equipment and consumables market research report are one of a series of new reports that provides anatomical pathology equipment and consumables market statistics, including anatomical pathology equipment and consumables industry global market size, regional shares, competitors with a anatomical pathology equipment and consumables market share, detailed anatomical pathology equipment and consumables market segments, market trends and opportunities, and any further data you may need to thrive in the anatomical pathology equipment and consumables industry. This anatomical pathology equipment and consumables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anatomical pathology equipment and consumables market consists of sales of microtome, automatic slide stainer, biomedical specimen cabinets, a cooling plate, and a paraffin trimmer/dispenser. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.